Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model

Published:2015-09-21 Issue:3 Volume:138 Page:758-769
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Hendrikx Jeroen J.M.A.¹²,Lagas Jurjen S.¹,Song Ji-Ying³,Rosing Hilde¹,Schellens Jan H.M.⁴⁵,Beijnen Jos H.¹⁵,Rottenberg Sven²,Schinkel Alfred H.²

Affiliation:

1. Department of Pharmacy & Pharmacology; The Netherlands Cancer Institute; Amsterdam The Netherlands

2. Division of Molecular Oncology; The Netherlands Cancer Institute; Amsterdam The Netherlands

3. Department of Experimental Animal Pathology; The Netherlands Cancer Institute; Amsterdam The Netherlands

4. Department of Clinical Pharmacology; The Netherlands Cancer Institute; Amsterdam The Netherlands

5. Department of Pharmaceutical Sciences; Utrecht University; Utrecht The Netherlands

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.29812/fullpdf

Reference49 articles.

1. Future scenarios for the treatment of advanced non-small cell lung cancer: focus on taxane-containing regimens;Grossi;Oncologist,2010

2. Docetaxel: its role in current and future treatments for advanced gastric cancer;Nishiyama;Gastric Cancer,2009

3. Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer;Belfiglio;J Cancer Res Clin Oncol,2012

4. Tubulin-targeted agents including docetaxel and cabazitaxel;Cheetham;Cancer J,2013

5. Intravenous-to-oral switch in anticancer chemotherapy: a focus on docetaxel and paclitaxel;Koolen;Clin Pharmacol Ther,2010

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessment;Cancer Chemotherapy and Pharmacology;2024-03-08

2. Ritonavir reverses resistance to docetaxel and cabazitaxel in prostate cancer cells with acquired resistance to docetaxel;Cancer Drug Resistance;2024-01-31

3. Resistance to taxane chemotherapies in prostate cancer;Therapy Resistance in Prostate Cancer;2024

4. Characterization of Novel Derivatives of MBQ-167, an Inhibitor of the GTP-binding Proteins Rac/Cdc42;Cancer Research Communications;2022-12-29

5. Time above threshold plasma concentrations as pharmacokinetic parameter in the comparison of oral and intravenous docetaxel treatment of breast cancer tumors;Anti-Cancer Drugs;2022-11-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3